Healthpeak Q3 FFO as Adjusted $0.45; raises FY guidance; lab leasing 733K sq ft

HEALTHPEAK PROPERTIES, INC.

2024-Q3 EPS reported $0.36 revenue$2,002,461,000

Net income $0.12/share; FFO as Adjusted $0.45; AFFO $0.41; same-store cash NOI growth 4.1%.
Raised 2024 FFO as Adjusted and AFFO guidance midpoint by +$0.01/share and same-store NOI growth by +50bps.
Expected merger synergies increased to ~$50M; 733K sq ft lab leases executed in Q3 and Oct 2024.
Outpatient medical leases: 3M sq ft with 89% retention; $37M development in Kansas City 100% pre-leased.
Board declared $0.30/share quarterly dividend (Nov 15 pay date); Net debt/Adjusted EBITDAre 5.1x.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.